There are 412 resources available
Designing neoadjuvant clinical trials: What is the right endpoint?
Presenter: Tatiana Prowell
Session: Clinical trials design: Novel designs
Resources:
Slides
Webcast
Decision making in post-neoadjuvant setting: The role of pCR, RCB, ctDNA, TILs and molecular features
Presenter: Carsten Denkert
Session: Post neoadjuvant systemic treatment decisions
Resources:
Slides
Webcast
Secondary use of existing health data for real-world analyses
Presenter: Antonis Valachis
Session: Practice changes based on real-world data
Resources:
Slides
Webcast
Unlocking the potential of biomarker-based trial designs in advancing new therapeutics
Presenter: Tomas Pascual
Session: Clinical trials design: Novel designs
Resources:
Slides
Webcast
Triple negative breast cancer (TNBC): Is there a standard treatment and does one size fit all?
Presenter: Helena Earl
Session: Post neoadjuvant systemic treatment decisions
Resources:
Slides
Webcast
Utilisation of real-world data for the pre marketing evaluations in oncology
Presenter: Diogo Martins Branco
Session: Practice changes based on real-world data
Resources:
Slides
Webcast
Statistical considerations in new clinical trials design
Presenter: Stefan Michiels
Session: Clinical trials design: Novel designs
Resources:
Slides
Webcast
HER2-positive: De-escalation and escalation strategies
Presenter: Evandro de Azambuja
Session: Post neoadjuvant systemic treatment decisions
Resources:
Slides
Webcast
Machine learning/artificial intelligence (AI) in real-world analyses
Presenter: Suzette Delaloge
Session: Practice changes based on real-world data
Resources:
Slides
Webcast
Q&A and discussion
Session: Clinical trials design: Novel designs
Resources:
Webcast